Potassium fluoride,anhydrous
           Potassium fluoride,extra pure
           Potassium fluoride,Granular
           Silicon Dioxide
           Hydrofluoric acid
           Synthetic Cryolite
           Potassium Fluoaluminate
           Ammonium bifluoride
           Potassium Bifluoride
           Aluminium fluoride
           Sodium fluoride
           Potassium Fluorosilicate
           Fluorosilicic Acid
           Sodium silicofluoride
           Potassium Hydroxide Flakes
           Magnesium Fluoride
           Magnesium fluorosilicate
           Barium Fluoride
  News Center

Hydrofluoric acid (HF) is an aqueous solution of hydrogen fluoride gas, there is a strong skin irritant and corrosive, once the improper operation of the contact HF, can cause skin burns. Because of its strong penetration, if not in time, the injured will have great pain, adverse psychological impact on patients, thus affecting the therapeutic effect. From February 2014, our hospital actively comprehensive care interventions to help patients improve the bad mood and feelings of treatment, such that the therapeutic effect of HF burns patients has been further improved.

Objective: To investigate the combination of intravenous calcium gluconate subcutaneously (CG) of hydrofluoric acid burn treatment efficacy and safety. Methods: January 2006 to August 2013 were treated 82 cases of hydrofluoric acid burn patients. On admission wound subcutaneous single injection CG, a dose of 30 ~ 45 mg / cm2 in 9 cases, 10 ~ 30 mg / cm232 cases, 5 ~ 10 mg / cm2 41 cases; Ⅰ degree wounds by 0.25 ~ 5.00 mg / cm2 of subcutaneous injection or the use of 2.5% CG wet solution. Subcutaneous injection CG 1 ~ 5 g total 57 cases, 5 ~ 10 g 14 Li, 10 ~ 20 g 10 Li, 20 ~ 30 g 1 case. At the same time dynamic monitoring of serum calcium, adjust speed according intravenous calcium calcium. 

Results: 82 cases of hydrofluoric acid burn patients were cured. 5 cases of hypocalcemia in patients within 4 h after admission obtain redress, 71 patients maintained serum calcium in the normal range, 6 patients hypercalcemia. All patients were followed up after a month or more, the injection area and no infection, subcutaneous nodules, and skin necrosis, and no record was deepened surface phenomenon. Conclusion: The combination of intravenous hypodermic CG is an effective method for treatment of hydrofluoric acid burns, but subcutaneous dose should be adjusted according to the patient's injury, avoid overdose hypercalcemia.